Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR)
- 1 July 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (14) , 3974-3977
- https://doi.org/10.1016/j.bmcl.2008.06.018
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A surface on the androgen receptor that allosterically regulates coactivator bindingProceedings of the National Academy of Sciences, 2007
- Human Pregnane X Receptor Antagonists and Agonists Define Molecular Requirements for Different Binding SitesMolecular Pharmacology, 2007
- Activated Pregnenolone X-Receptor Is a Target for Ketoconazole and Its AnalogsClinical Cancer Research, 2007
- The Dietary Isothiocyanate Sulforaphane Is an Antagonist of the Human Steroid and Xenobiotic Nuclear ReceptorMolecular Pharmacology, 2007
- Crystal structure of the PXR–T1317 complex provides a scaffold to examine the potential for receptor antagonismBioorganic & Medicinal Chemistry, 2006
- In Vivo Activation of Human Pregnane X Receptor Tightens the Blood-Brain Barrier to Methadone through P-Glycoprotein Up-RegulationMolecular Pharmacology, 2006
- Cytochrome P450 active site plasticity: attenuation of imidazole binding in cytochrome P450cam by an L244A mutationProtein Engineering, Design and Selection, 2006
- A study of cytotoxic synergy of UCN-01 and flavopiridol in syngeneic pair of cell linesInvestigational New Drugs, 2005
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995